Stock AnalizIcu Medical Inc ICUI
Medical/Dental Instruments · IPO 1992 · data as of November 13, 2026
Icu Medical Inc (ICUI) is a healthcare company listed in the US with a market value of about $4.5B. In the twelve months to September 30, 2026 it had revenue of $2.2B and net income of $60M, a net margin of 2.8%.
Its overall Stock Analiz score is 1.0 out of 5 (weak). The strongest part is financial health (2/5); the weakest is value (0/5).
Key numbers: a P/E of 74.7, a price to free cash flow of 21.5, 5-year revenue growth of 12% a year, a 5-year average ROIC of 1%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 61% below the current price.
Score: 1.0 / 5
Checks passed
- Profit margin improving
- 5-year revenue growth above 8% a year
- Positive free cash flow
- Liabilities below 60% of assets
- Stock-based pay below 5% of revenue
Checks not passed
- P/E below 25
- P/E below the industry median
- P/FCF below 20
- Price below intrinsic value (DCF, moderate assumptions)
- PEG below 1.5
- Revenue growth above 10% last year
- 3-year revenue growth above 10% a year
- 3-year free cash flow growth above 10% a year
Valuation
Growth and quality
Financials, last 10 years
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.2B | $2.2B | $2.4B | $2.3B | $2.3B | $1.3B | $1.3B | $1.3B | $1.4B | $1.3B | $379M |
| Net income | $60M | $732000 | -$118M | -$30M | -$74M | $103M | $87M | $101M | $29M | $69M | $63M |
| Free cash flow | $209M | $92M | $125M | $82M | -$152M | $199M | $131M | $5M | $67M | $80M | $67M |
| EPS (diluted) | $2.40 | $0.03 | $-4.83 | $-1.23 | $-3.11 | $4.74 | $4.02 | $4.69 | $1.33 | $3.29 | $3.66 |
| Net margin | 2.8% | 0.0% | -4.9% | -1.3% | -3.3% | 7.8% | 6.8% | 8.0% | 2.1% | 5.3% | 16.6% |
| ROIC | — | 1.0% | 0.9% | 0.5% | -0.9% | 5.9% | 5.6% | 6.3% | 1.8% | -0.8% | 9.3% |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
What analysts expect
The average 12-month price target from 8 analysts is $194.25, 8% above the current price; targets range from $178.00 to $210.00; the consensus rating is “Buy”; expected EPS is $8.93 for the fiscal year ending December 31, 2026.
Frequently asked questions
What is Icu Medical’s P/E ratio?
About 74.7, based on the last twelve months of diluted earnings per share (forward P/E about 19.6).
Is Icu Medical stock undervalued?
Our DCF model with moderate assumptions puts its intrinsic value about 61% below the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.
Does Icu Medical pay a dividend?
Not currently.
Is Icu Medical a good stock to buy?
We do not give buy or sell advice. Icu Medical scores 1.0 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.